Xing-Mei Cao
- Topics
- Acute Myeloid Leukemia Research (9 papers)Neutropenia and Cancer Infections (6 papers)Multiple Myeloma Research and Treatments (5 papers)
- Cited by
- HematologyImmunologyOncology
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Xing-Mei Cao
32 papers receiving 498 citations
Peers
Comparison fields: 5 of 70
- Oncology 218
- Molecular Biology 191
- Immunology 188
- Hematology 179
- Genetics 59
Countries citing papers authored by Xing-Mei Cao
This map shows the geographic impact of Xing-Mei Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing-Mei Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing-Mei Cao more than expected).
Fields of papers citing papers by Xing-Mei Cao
This network shows the impact of papers produced by Xing-Mei Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing-Mei Cao. The network helps show where Xing-Mei Cao may publish in the future.
Co-authorship network of co-authors of Xing-Mei Cao
This figure shows the co-authorship network connecting the top 25 collaborators of Xing-Mei Cao. A scholar is included among the top collaborators of Xing-Mei Cao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing-Mei Cao. Xing-Mei Cao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 77 | |
| 3 | 2 | |
| 4 | 49 | |
| 5 | 0 | |
| 6 | 43 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 9 | |
| 10 | 3 | |
| 11 | 10 | |
| 12 | 16 | |
| 13 | 8 | |
| 14 | Efficiency of HAG priming therapy on older patients with acute myeloid leukemia | 1 |
| 15 | 21 | |
| 16 | 10 | |
| 17 | ru he shen he chu fang yong yao de shi yi xing | 2 |
| 18 | [Positive immunoregulation of thalidomide on human peripheral blood mononuclear cell cultures]. | 2 |
| 19 | 35 | |
| 20 | 37 |
About Xing-Mei Cao
Xing-Mei Cao is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 33 papers that have together received 509 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Neutropenia and Cancer Infections (6 papers) and Multiple Myeloma Research and Treatments (5 papers). The work is most often cited by research in Hematology (179 citations), Immunology (188 citations) and Oncology (218 citations). Xing-Mei Cao has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Wanggang Zhang, Yinxia Chen, Aili He, Wanhong Zhao, Liufang Gu, Jie Liu, Fangxia Wang, Pengyu Zhang, Bo Lei and Yilin Zhang. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.